Delcath Systems (DCTH) Competitors $15.96 -0.25 (-1.54%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$16.27 +0.31 (+1.94%) As of 06/11/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCTH vs. WRBY, NVCR, LMAT, CNMD, ENOV, EYE, LQDA, TNDM, CDRE, and AORTShould you be buying Delcath Systems stock or one of its competitors? The main competitors of Delcath Systems include Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), CONMED (CNMD), Enovis (ENOV), National Vision (EYE), Liquidia (LQDA), Tandem Diabetes Care (TNDM), Cadre (CDRE), and Artivion (AORT). These companies are all part of the "medical equipment" industry. Delcath Systems vs. Its Competitors Warby Parker NovoCure LeMaitre Vascular CONMED Enovis National Vision Liquidia Tandem Diabetes Care Cadre Artivion Delcath Systems (NASDAQ:DCTH) and Warby Parker (NYSE:WRBY) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking. Is DCTH or WRBY more profitable? Warby Parker has a net margin of -4.39% compared to Delcath Systems' net margin of -150.70%. Warby Parker's return on equity of -8.26% beat Delcath Systems' return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems-150.70% -338.16% -104.02% Warby Parker -4.39%-8.26%-4.37% Does the media refer more to DCTH or WRBY? In the previous week, Warby Parker had 4 more articles in the media than Delcath Systems. MarketBeat recorded 5 mentions for Warby Parker and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.87 beat Warby Parker's score of 1.19 indicating that Delcath Systems is being referred to more favorably in the media. Company Overall Sentiment Delcath Systems Very Positive Warby Parker Positive Which has stronger valuation and earnings, DCTH or WRBY? Delcath Systems has higher earnings, but lower revenue than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$53.85M10.32-$47.68M-$0.50-31.92Warby Parker$795.09M2.97-$63.20M-$0.12-188.12 Do analysts recommend DCTH or WRBY? Delcath Systems presently has a consensus target price of $24.00, suggesting a potential upside of 50.38%. Warby Parker has a consensus target price of $22.88, suggesting a potential upside of 1.33%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts clearly believe Delcath Systems is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Warby Parker 0 Sell rating(s) 7 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.61 Do institutionals and insiders hold more shares of DCTH or WRBY? 61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 17.4% of Delcath Systems shares are held by insiders. Comparatively, 18.2% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community favor DCTH or WRBY? Warby Parker received 19 more outperform votes than Delcath Systems when rated by MarketBeat users. Likewise, 46.61% of users gave Warby Parker an outperform vote while only 29.27% of users gave Delcath Systems an outperform vote. CompanyUnderperformOutperformDelcath SystemsOutperform Votes3629.27% Underperform Votes8770.73% Warby ParkerOutperform Votes5546.61% Underperform Votes6353.39% Which has more risk & volatility, DCTH or WRBY? Delcath Systems has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. SummaryWarby Parker beats Delcath Systems on 12 of the 18 factors compared between the two stocks. Get Delcath Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DCTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCTH vs. The Competition Export to ExcelMetricDelcath SystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$555.82M$4.41B$5.57B$8.61BDividend YieldN/A42.67%5.28%4.18%P/E Ratio-11.8228.4427.1720.06Price / Sales10.3271.85409.72157.10Price / CashN/A51.0838.2534.64Price / Book22.175.917.064.70Net Income-$47.68M$67.63M$3.23B$247.88M7 Day Performance-5.39%2.35%2.89%2.66%1 Month Performance10.45%17.24%9.06%6.40%1 Year Performance122.59%19.59%31.40%14.07% Delcath Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCTHDelcath Systems3.5612 of 5 stars$15.96-1.5%$24.00+50.4%+132.0%$555.82M$53.85M-11.8260WRBYWarby Parker2.0805 of 5 stars$21.49+1.5%$22.88+6.4%+35.5%$2.25B$795.09M-79.603,030Positive NewsNVCRNovoCure4.0599 of 5 stars$17.04-10.8%$32.83+92.7%-18.9%$1.90B$621.71M-12.171,320High Trading VolumeLMATLeMaitre Vascular2.9261 of 5 stars$80.40-2.2%$97.83+21.7%+7.1%$1.82B$226.26M43.93490Positive NewsCNMDCONMED4.0365 of 5 stars$55.32-2.5%$62.20+12.4%-23.3%$1.71B$1.32B13.054,100ENOVEnovis2.7239 of 5 stars$29.62-5.4%$58.00+95.8%-25.5%$1.69B$2.15B-13.536,800High Trading VolumeEYENational Vision3.2671 of 5 stars$21.19+7.0%$17.75-16.2%+49.6%$1.68B$1.85B-105.9414,000Positive NewsHigh Trading VolumeLQDALiquidia3.7554 of 5 stars$16.87+13.1%$26.67+58.1%+2.3%$1.44B$14.14M-10.3550Trending NewsAnalyst ForecastOptions VolumeHigh Trading VolumeTNDMTandem Diabetes Care4.0385 of 5 stars$20.22+2.0%$35.86+77.3%-55.5%$1.35B$982.95M-10.482,600Positive NewsCDRECadre2.9938 of 5 stars$32.97+0.6%$37.00+12.2%+7.1%$1.34B$559.81M39.722,240Positive NewsAORTArtivion2.5233 of 5 stars$28.74-2.8%$31.40+9.3%+23.6%$1.23B$390.08M-1,437.001,300Short Interest ↓ Related Companies and Tools Related Companies Warby Parker Competitors NovoCure Competitors LeMaitre Vascular Competitors CONMED Competitors Enovis Competitors National Vision Competitors Liquidia Competitors Tandem Diabetes Care Competitors Cadre Competitors Artivion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCTH) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredAnother market crash is coming - here's whenMagnificent 7 Wipeout: What's Next? The first quarter stock crash and quick recovery has many people confus...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Delcath Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Delcath Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.